Longevity Investors & VC Firms in London
17 firms in this list, with a median first check of $320K. 3 of them lead rounds. Generated from verified public data and updated continuously.
SV Health Investors
BostonPre-Seed–Late Stage$1M – $20M
29 people
Advent Life Sciences
LondonSeed–Late Stage
29 people
Unruly Capital
LondonPre-Seed–Series A
3 people
Ahren Innovation Capital
Cambridge, CambridgeshirePre-Seed–Late Stage
30 people
Hiro Capital
LondonSeries A–Late Stage
24 people
Exceptional Ventures
LondonPre-Seed–Series A
19 people
Delin Ventures
LondonPre-Seed–Series A$216K – $2.2M
21 people
UCL Technology Fund
LondonPre-Seed–Growth$320K – $9M
13 people
Brookstreet Equity Partners
LondonPre-Seed–Growth
20 people
Nordstar
LondonGrowth–Late Stage
9 people
Aweh Ventures
LondonPre-Seed–Series A
3 people
Dementia Discovery
LondonPre-Seed–Series C
6 people
Deep Knowledge Group
LondonSeed
7 people
Selvedge Venture
LondonPre-Seed–Series A
3 people
Embryo Ventures
LondonPre-Seed–Series A
NJF Capital
LondonSeed–Late Stage
1 person
Crista Galli Ventures
LondonPre-Seed–Series A
Related lists
Investors & VC Firms in United States (5050)Crypto & Web3 Investors & VC Firms (4688)Investors & VC Firms in Global (4044)SaaS Investors & VC Firms (3602)AI & Machine Learning Investors & VC Firms (3577)Fintech Investors & VC Firms (3506)Healthtech Investors & VC Firms (3208)Enterprise Software Investors & VC Firms (3098)Investors & VC Firms in Europe (2833)Consumer Investors & VC Firms (2381)
Data sourced from public filings and firms' own websites — see our methodology.










































